Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

Similar articles for PubMed (Select 19736165)

1.

Efficacy of cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials.

Tamhane U, Meier P, Chetcuti S, Chen KY, Rha SW, Grossman MP, Gurm H.

EuroIntervention. 2009 Aug;5(3):384-93. Review.

PMID:
19736165
2.

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials.

Navarese EP, Andreotti F, Schulze V, Kołodziejczak M, Buffon A, Brouwer M, Costa F, Kowalewski M, Parati G, Lip GY, Kelm M, Valgimigli M.

BMJ. 2015 Apr 16;350:h1618. doi: 10.1136/bmj.h1618.

3.

Dual Antiplatelet Therapy in Patients with Glucose-6-Phosphate Dehydrogenase Deficiency undergoing PCI with Drug-Eluting Stents.

Biscaglia S, Ferri A, Pavasini R, Campo G, Ferrari R.

J Atheroscler Thromb. 2015 May 20;22(5):535-41. doi: 10.5551/jat.29371. Epub 2015 Apr 3.

4.

Efficacy and Safety of Cilostazol Therapy in Ischemic Stroke: A Meta-analysis.

Tan L, Margaret B, Zhang JH, Hu R, Yin Y, Cao L, Feng H, Zhang Y.

J Stroke Cerebrovasc Dis. 2015 May;24(5):930-8. doi: 10.1016/j.jstrokecerebrovasdis.2014.12.002. Epub 2015 Mar 21.

PMID:
25804574
5.

Cilostazol may prevent cardioembolic stroke in patients undergoing antiplatelet therapy.

Horie N, Kaminogo M, Izumo T, Hayashi K, Tsujino A, Nagata I.

Neurol Res. 2015 Jul;37(7):619-23. doi: 10.1179/1743132815Y.0000000021. Epub 2015 Mar 23.

PMID:
25798683
6.

Antiplatelet therapy as a modulator of stroke aetiology: a meta-analysis.

Rajkumar CA, Floyd CN, Ferro A.

Br J Clin Pharmacol. 2015 Mar 17. doi: 10.1111/bcp.12630. [Epub ahead of print]

PMID:
25784356
7.

Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial.

Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L; Dual Antiplatelet Therapy (DAPT) Study Investigators.

JAMA. 2015 Mar 17;313(11):1113-21. doi: 10.1001/jama.2015.1671. Erratum in: JAMA. 2015 Jun 2;313(21):2185.

8.

Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials.

Giustino G, Baber U, Sartori S, Mehran R, Mastoris I, Kini AS, Sharma SK, Pocock SJ, Dangas GD.

J Am Coll Cardiol. 2015 Apr 7;65(13):1298-310. doi: 10.1016/j.jacc.2015.01.039. Epub 2015 Feb 11. Review.

PMID:
25681754
9.

Effectiveness of cilostazol in the treatment of peripheral arterial obstruction.

Rybak Z.

Pol Arch Med Wewn. 2015;125(3):117-9. Epub 2015 Jan 19. No abstract available.

10.

Cilostazol increases patency and reduces adverse outcomes in percutaneous femoropopliteal revascularisation: a meta-analysis of randomised controlled trials.

Benjo AM, Garcia DC, Jenkins JS, Cardoso RM, Molina TP, El-Hayek GE, Nadkarni GN, Aziz EF, Dinicolantonio JJ, Collins T.

Open Heart. 2014 Nov 4;1(1):e000154. doi: 10.1136/openhrt-2014-000154. eCollection 2014.

11.

Efficacy of cilostazol on platelet reactivity and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: insights from a meta-analysis of randomised trials.

Bangalore S, Singh A, Toklu B, DiNicolantonio JJ, Croce K, Feit F, Bhatt DL.

Open Heart. 2014 Aug 7;1(1):e000068. doi: 10.1136/openhrt-2014-000068. eCollection 2014.

12.

[Perioperative management of thyroid surgery in patients treated with drug-eluting stents].

Ohno T, Mizukoshi A, Kimura T, Tamaki H.

Nihon Jibiinkoka Gakkai Kaiho. 2014 Aug;117(8):1120-5. Japanese.

PMID:
25255652
13.

Meta-analysis of randomized trials comparing the effectiveness of different strategies for the treatment of drug-eluting stent restenosis.

Piccolo R, Galasso G, Piscione F, Esposito G, Trimarco B, Dangas GD, Mehran R.

Am J Cardiol. 2014 Nov 1;114(9):1339-46. doi: 10.1016/j.amjcard.2014.07.069. Epub 2014 Aug 12. Review.

PMID:
25242363
14.

Effect of Cilostazol Following Endovascular Intervention for Peripheral Artery Disease.

Nanto K, Iida O, Takahara M, Soga Y, Suzuki K, Hirano K, Kawasaki D, Shintani Y, Suematsu N, Yamaoka T, Uematsu M.

Angiology. 2014 Sep 15. pii: 0003319714551361. [Epub ahead of print]

PMID:
25228649
15.

Efficacy of two different self-expanding nitinol stents for atherosclerotic femoropopliteal arterial disease (SENS-FP trial): study protocol for a randomized controlled trial.

Park SH, Rha SW, Choi CU, Kim EJ, Oh DJ, Cho YH, Choi WG, Lee SJ, Kim YH, Choi SH, Kim WH, Kim KC, Cho JH, Kim JH, Kim SM, Bae JH, Bong JM, Kang WY, Baek JY, Seo JB, Chung WY, Park MW, Her SH, Suh J, Kim MW, Kim YJ, Choi HJ, Soh JW; SENS-FP Investigators.

Trials. 2014 Sep 10;15:355. doi: 10.1186/1745-6215-15-355.

16.
17.

Generation bias in meta-analysis of duration of dual antiplatelet therapy following drug-eluting stent.

Salman S.

Am J Cardiol. 2014 Dec 1;114(11):1786. doi: 10.1016/j.amjcard.2014.07.057. Epub 2014 Aug 4. No abstract available.

PMID:
25175158
18.

Short versus long duration of DAPT after DES implantation: a meta-analysis.

Stefanini GG, Siontis GC, Cao D, Heg D, Jüni P, Windecker S.

J Am Coll Cardiol. 2014 Sep 2;64(9):953-4. doi: 10.1016/j.jacc.2014.06.1158. No abstract available.

PMID:
25169183
19.

Pharmacological inhibition of coronary restenosis: systemic and local approaches.

Guerra E, Byrne RA, Kastrati A.

Expert Opin Pharmacother. 2014 Oct;15(15):2155-71. doi: 10.1517/14656566.2014.948844. Epub 2014 Aug 22. Review.

PMID:
25145263
20.

Case scenario: a patient on dual antiplatelet therapy with an intracranial hemorrhage after percutaneous coronary intervention.

Naik BI, Keeley EC, Gress DR, Zuo Z.

Anesthesiology. 2014 Sep;121(3):644-53. doi: 10.1097/ALN.0000000000000350. No abstract available.

PMID:
24950163
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk